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OBJECTIVES: To examine associations between nocturia
and potentially modifiable risk factors in older adults.
DESIGN: Secondary analysis of cross-sectional and longi-
tudinal data.
SETTING: Respondents were selected using population-
based sampling, drawing from a single Michigan county in
1983. They were followed through 1990.
PARTICIPANTS: Community-living adults aged 60 and
older.
MEASUREMENTS: Episodes of nocturia, development of
nocturia at 2 years after baseline survey, age, sex, hyper-
tension, diabetes mellitus, drinking fluids before bedtime,
amount of fluid intake before bedtime, diuretic use, and
24-hour coffee intake. All measures were self-reported.
RESULTS: Bivariate cross-sectional analysis revealed sig-
nificant associations with two or more episodes of nocturia
for hypertension (odds ratio (OR) 5 1.7, 95% confidence
interval (CI) 5 1.37–2.1), diabetes mellitus (OR 5 1.51,
95% CI 5 1.1–2.0), diuretic use (OR 5 1.7, 95% CI 5 1.3–
2.1), age (OR 5 1.05 per additional year over 60, 95%
1.03–1.06), and number of cups of coffee (OR 5 0.93 for
each cup of coffee, 95% CI 5 0.89–0.97). In multivariate
analysis, hypertension (OR 5 1.52, 95% CI 5 1.2–1.9), di-
uretic use (OR 5 1.3, 95% 95% CI 5 1.0–1.7), and age
(OR 5 1.04 per additional year over 60, 95% 1.03–1.06)
were independently associated with two or more nocturia
episodes per night. No baseline factors predicted future de-
velopment of nocturia (save for age, in one model).
CONCLUSION: Hypertension, older age, and diuretic use
were independently associated with two or more episodes
of nocturia in cross-sectional analysis. No baseline factor
was related to the development of nocturia over a 2-year
interval in this sample. Nighttime fluid intake and coffee
intake, practices providers commonly target in patients
with nocturia, were not associated with nocturia in this
population-based sample of community-living older adults.
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Nocturia, defined as waking at night to void,
1 is com-
mon2 and occurs with increasing frequency with ad-
vancing age. For older adults, nocturia is a significant cause
of sleep disruption3 and is associated with double the risk of
falling.4 Nocturia has been rated as one of the most both-
ersome lower urinary tract symptoms.5,6
Often, practitioners recommend to their patients be-
havioral modifications (drink less water at night, reduce
coffee) or focus on managing certain conditions (improving
diabetes mellitus control) to treat nocturia, but whether
such potentially modifiable factors are associated with noc-
turia is uncertain. Population-based studies on nocturia7–14
have largely been inventories of urological symptoms.
Although these studies provide prevalence estimates, they
provide limited insight into the epidemiology of nocturia.
Clinic-based populations have many clinical details on the
participants,2,15,16 yet these referral-based samples are not
representative of the general population, limiting general-
izability. There are few longitudinal studies of voiding
symptoms.17 No study has examined, in older adults,
whether potentially modifiable risk factors for nocturia
predict future development of nocturia.
The purpose of these analyses was to examine cross-
sectional and longitudinal data to determine whether sev-
eral potentially modifiable risk factors were associated with
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nocturia. The a priori hypothesis was that specific risk fac-
tors presumed to be related to nocturia, such as nighttime
fluid intake and hypertension, would be significantly asso-
ciated with the presence and development of nocturia.
METHODS
Data from the Medical, Epidemiologic, and Social aspects
of Aging (MESA) Study, a population-based, community
sample of noninstitutional adults aged 60 and older, ini-
tially collected in 1983, were used in these analyses. The
institutional review board of the University of Michigan
approved the MESA study. Trained interviewers conducted
in-person interviews with 1,956 participants in 1983/84
(baseline). Additional data were collected in 1984/85
(n 5 1,334, Year 1 follow-up), 1985/86 (n 5 1,289, Year 2
follow-up), and 1989/90 (n 5 1,199, Year 6 follow-up). Al-
though the baseline and Year 2 follow-up data were the
source of the longitudinal results reported in this paper, the
Year 1 and Year 6 follow-up data were also examined.
These data have been particularly valuable because of the
detailed questioning used to describe the epidemiology of
voiding problems in general and urinary incontinence in
particular.18–24 For this secondary analysis, participants’
anonymity was guaranteed through the use of an investi-
gator agreement, and all direct identifiers were removed
from the database.
For the nocturia variable, the question, ‘‘Generally,
how many times do you usually urinate after you have gone
to sleep at night?’’ was used. The wording of this question is
fairly consistent with the International Continence Society
definition of nocturia published in 2002,1 except that an
interviewer instruction not read aloud told the interviewer
to include nighttime urinary incontinence if mentioned. Be-
cause of a slight change in the wording of the nocturia
question (from ‘‘How many times do you usually urinate
after you have gone to sleep?’’ in baseline and Years 1 and 2
follow-up surveys to ‘‘usually urinate after you have fallen
asleep at night’’), Year 6 follow-up data were not used for
any longitudinal analyses.
Nocturia was dichotomized into two or more (noc-
turia) and less than two (no nocturia); an alternative cut-
point at three or more and less than three was also exam-
ined. Where nocturia was managed as an ordinal variable in
additional analyses, persons reporting five or more episodes
were collapsed into a category ‘‘five or more episodes.’’
To be categorized as having incident nocturia, a par-
ticipant must have reported zero or one episode of nocturia
per night at baseline and reported two or more episodes of
nocturia at the 2-year follow-up. Alternative coding strat-
egies for incident nocturia were also explored: (1) those
with zero or one episode of nocturia at baseline would be
considered incident if they had an increase of two or more
additional episodes; and (2) those with zero episodes of
nocturia at baseline would be considered incident with any
future episode of nocturia at follow-up.
Variables suggested in the literature as contributing to
or causing nocturia were included in the analyses; each ad-
ditional year of age over 60, taking fluid intake at night
(percentage of an 8-ounce serving), and number of cups of
coffee in a 24-hour period (all continuous variables); being
told by a doctor that you have hypertension, being told by a
doctor that you have diabetes mellitus, being male, drinking
fluids at night, and taking a diuretic (all dichotomous var-
iables). Coffee drinking was recorded as total number of
cups per day but not as caffeinated or decaffeinated.
Following the a priori analyses just described, correla-
tional analyses were performed of nocturia reports at each
time point (baseline, Year 1 follow-up, and Year 2 follow-
up). Additional analyses of the correlation of nocturia re-
ports over time were performed, restricting the sample to
(1) those with higher levels of education and only those with
zero episodes or three or more episodes of nocturia. An
additional cross-sectional analysis of Year 6 follow-up data
was used to attempt to reproduce cross-sectional multi-
variate analysis performed on baseline data.
SPSS 11.0 was used for all analyses (SPSS, Inc., Chi-
cago, IL). Variables were evaluated for coding errors by
inspecting range, mean, and median values. To examine for
collinearity between the variables, a correlational analysis
was used. Effect modification by age or sex of each variable
with respect to nocturia was examined. Variables related in
bivariate analysis to nocturia with Po.10 were further
evaluated in backwards stepwise multivariable logistic re-
gression. The criterion for inclusion in the model was
Po.05, with a variable withdrawn if P4.10. If no signif-
icant associations were found in bivariate analysis, no mul-
tivariate analyses were performed. Models were repeated
with the previously described alternative coding strategies
for nocturia and incident nocturia.
RESULTS
Figure 1 shows the progression of study participants from
baseline through Year 2 follow-up and their responses to
nocturia questions. Of the original 1,956 MESA partici-
pants at the baseline survey, 1,632 (83.4%) answered the
question on nocturia (Table 1). Of these 1,632 participants,
31%, 37%, 20%, 8%, 3%, and 1% reported zero, one,
two, three, four, and five or more episodes of nocturia, re-
spectively. As for the collapse of the highest categories, only
1% of those answering the nocturia question had six or
more episodes of nocturia. For respondents by age and sex
at baseline, in men aged 60 to 69, 70 to 79, and 80 and
older, 25.6%, 37.7%, and 57.1% reported two or more
episodes of nocturia, respectively. In women aged 60 to 69,
70 to 79, and 80 and older, 26.9%, 35.5%, and 42.3% had
two or more episodes of nocturia, respectively.
By Year 2 follow-up, there were 1,289 respondents
(66% of the original sample). At Year 2 follow-up, 99.2%
(n 5 1,279) of the sample answered the nocturia question.
Of these 1,279 respondents, 28%, 39%, 19%, 10%, 3%,
and 2% reported zero, one, two, three, four, and five or
more episodes of nocturia, respectively. Of the 748 Year 2
follow-up respondents who reported zero or one nocturia
episodes at baseline, 259 (34.6%) reported two or more
episodes of nocturia (incident nocturia). Of those who re-
ported two or more episodes of nocturia at baseline and
answered the nocturia question at Year 2 follow-up
(n 5 357), 237 (66.4%) reported zero or one episode of
nocturia (remitting nocturia). Because there was no effect
on the results of placing the cutpoint at three, only the re-
sults of the cutpoint at two have been reported.
1012 JOHNSON ET AL. JUNE 2005–VOL. 53, NO. 6 JAGS
The initial 1,956 members of the sample did not differ
significantly from subjects at Year 1 follow-up or Year 2
follow-up with respect to age at baseline or sex (analysis not
shown). There was a difference in mean age, but not sex,
between nonresponders and responders. No important col-
linearity between the variables was detected, and no effect
modification by age or sex was found for any variable rel-
evant to nocturia.
Table 2 illustrates the results from bivariate and mul-
tivariate analyses of risk factors for nocturia. For the mul-
tivariate analyses, only variables retained in the final model
have odds ratios reported.
No baseline variables examined (male sex, hyperten-
sion, diabetes mellitus, bedtime fluids/amount of bedtime
fluids, diuretic use, age, coffee intake) were associated with
incident nocturia at 2 years. All point estimates for these
bivariate odds ratios were between 0.88 and 1.02. Alter-
native codings of nocturia (3, o3) and a different length
of follow-up (1 year) were also employed, with little dif-
ference in the results except when incident nocturia was
coded as going from zero episodes of nocturia to one or
more episodes. Using that categorization, age was statisti-
cally associated with incident nocturia at 1 year (odds ratio
(OR) 5 1.03, 95% confidence interval (CI) 5 1.00–1.07)
but not 2 years (OR 5 0.98, 95% CI 5 0.95–1.01). Because
no coding yielded significant associations in bivariate anal-
yses (other than age in one model), no multivariate analyses
for incident nocturia were performed.
There were several additional analyses performed post
hoc, as described in the Methods section; these results are
No answer for 
nocturia question 
n = 324 
Answered nocturia 
question 
n = 1,632 
MESA 1985/1986 
Year 2 Follow-Up 
n = 1,289 
Dropped out 
n = 667 
Had 0 or 1 episode 
at baseline 
n = 748 
Answers at
baseline survey
and Year 3 follow-
up answer
n = 1,105
No baseline nocturia 
answer, but Year 2 
follow-up answer 
n = 174
No Year 2 
follow-up 
nocturia answer
n = 10 




Had ≥ 2 episodes
nocturia at baseline
n = 520
Had ≥ 2 episodes
nocturia at baseline
n = 357
Had 0 or 1 episode 
at Year 2 follow-up 
n = 489 
Had ≥ 2 episodes of
nocturia at Year 2 
follow-up 
n = 120 




Had ≥ 2 episodes of
nocturia at Year 2 
follow-up 
n = 259 
MESA 1983/1984 
Baseline Survey 
N = 1,956 
Figure 1. Flow chart of participants in the Medical, Epidemiologic, and Social aspects of Aging (MESA) Study. Chart shows how
participants in baseline and follow-up survey were tracked through waves. Ratio for incident nocturia calculated by taking N of
‘‘Having two or more episodes of nocturia at Year 2 follow-up’’ (n 5 259) and dividing by ‘‘Had 0 or 1 nocturia episode at baseline’’
(n 5 748).
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enumerated here. Nocturia reports at different waves were
negligibly correlated. Pearson correlations were 0.02 (base-
line and Year 1 follow-up), 0.02 (baseline and Year 2
follow-up), and 0.08 (Year 1 follow-up and Year 2 follow-
up); only Year 1 and Year 2 follow-up reports were signif-
icantly correlated (n 5 1,265, P 5.05). Restricting the sam-
ple to those with a high school education or greater made
little substantive difference in the correlations. The Pearson
correlations were  0.04 (baseline and Year 1 follow-up),
0.02 (baseline and Year 2 follow-up), and 0.17 (Year 1
follow-up and Year 2 follow-upFa statistically significant
correlation Po.05).
These correlations were repeated, restricting the sam-
ple to respondents who had zero or three or more episodes
of nocturia. At baseline and Year 1 and Year 2 follow-
up, there were 498, 352, and 401 participants who had
zero episodes and 199, 195, and 158 who had three or
more episodes of nocturia, respectively. Between Year 1 and
Year 2 follow-up, those who reported three or more
episodes of nocturia were significantly more likely
(w2 P 5.048) to report three or more episodes of nocturia
at Year 2 follow-up. All other comparisons between waves
were nonsignificant.
Repeating the baseline multivariable analysis using
Year 6 follow-up data yielded slightly different results. With
baseline data, being told that you have hypertension, re-
porting diuretic use, and age were independently significant
in multivariate analyses. Using Year 6 follow-up data and
beginning with the same set of variables (age, hypertension,
diabetes mellitus, coffee drinking, and reporting diuretic
use), a slightly different model resulted. For Year 6 follow-
up data, age (OR 5 1.04, 95% CI 5 1.02, 1.06), diuretic
use (OR 5 1.58, 95% CI 5 1.21, 2.07), and diabetes mel-
litus (OR 5 1.52, 95% CI 5 1.06, 2.17) were related to
reporting two or more episodes of nocturia.
DISCUSSION
In this population-based sample of community-living adults
aged 60 and older, hypertension, advanced age, and diuretic
use were independently associated with having two or more
episodes of nocturia in cross-sectional analysis. Year 6













Age, mean 68.9 71.5w 69.7 71.5z
Male, % 40.6 41.0 40.7 42.6
Amount of liquid at bedtime, ounces 10.0 10.7 10.2 F
Cups of coffee per day 2.8 2.4 2.7 F
Diuretic use, % 28.2 39.7w 31.9 F
Drinking liquids at bedtime, % 77.0 76.6 76.9 F
Told by doctor that you have diabetes mellitus, % 12.4 17.6 14.2 F
Told by doctor that you have hypertension, % 44.0 57.1w 48.2 F
Po.05, w .001 for difference between those with nocturia and those without nocturia.
zPo.001 for difference between respondents to nocturia and nonrespondents to nocturia question.
F5 percentages suppressed because n 10 for these categories.
Table 2. Factors Associated in Cross-Sectional Bivariate and Multivariate Analyses with Having Two or More Episodes of
Nocturia
Factor
Bivariate Analysis Multivariate Analysisw
Odds Ratio (95% Confidence Interval)
Dichotomous variables
Being male 1.02 (0.82–1.26)
Being told by a doctor that you have hypertension 1.70 (1.38–2.10) 1.52 (1.19–1.94)
Being told by a doctor that you have diabetes 1.51 (1.13–2.01)
Having fluids at bedtime 0.97 (0.76–1.25)
Using a diuretic 1.67 (1.34–2.09) 1.31 (1.01–1.69)
Continuous variables
Age, in years 1.05 (1.03–1.06) 1.04 (1.03–1.06)
Amount of fluids at bedtime (% of an 8-ounce cup) 1.05 (0.96–1.15)
Number of cups of coffee in a 24-hour period 0.93 (0.89–0.97)
Maximum n 5 1,632 for each bivariate analysis based upon missing values in nocturia response.
wn 5 1,563 for this multivariate analysis.
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follow-up data (but not baseline) showed an independent
association between diabetes mellitus and nocturia. Total
24-hour coffee drinking was associated with reporting less
nocturia in bivariate analysis. Despite the fact that practi-
tioners often encourage decreased nighttime fluid drinking,
no measure of nighttime fluid intake in this sample was
associated with nocturia. In longitudinal analyses, no base-
line factor was related to the development of nocturia over a
2-year interval. An epidemiological framework was used
for these analyses, based on the reasoning that, if a poten-
tially modifiable risk factor were shown to be associated
with nocturia or incident nocturia, it would be a reasonable
factor on which to intervene. Alternatively, if no such as-
sociation were found, it might not be a reasonable target.
These results are congruent with other studies. Hyper-
tension has previously been shown to be associated with
nocturnal polyuria and nocturia.25,26 Hypertension might
be related to nocturia by its effect on cardiovascular phys-
iology (edema, congestive heart failure with atrial stretch
and release of atrial natriuretic peptide) or renal physiology
(renal effects on glomerular filtration and tubular trans-
port). Hypertension may cause resetting of the pressure-
natriuresis relation in the kidney.26 Diabetes mellitus affects
renal physiology. In the short term, poorly controlled dia-
betes mellitus causes glucosuria and polyuria. (Although
this would cause polyuria in the day and night and not
specifically nocturnal polyuria.)
Although not previously described, an association be-
tween diuretic use and nocturia is biologically plausible.
Diuretic use may be related to nocturia because of its re-
lationship with hypertension, congestive heart failure, or
peripheral edema. Alternatively, participants may have used
diuretics in the afternoon as a treatment for nocturia.27 Had
diuretic use predicted the future development of nocturia,
the temporal relationship between diuretic use and nocturia
would be more certain.
These results did not support some commonly held be-
liefs. More than 65% of all participants (with and without
nocturia) reported bedtime fluid intake. Neither bedtime
fluid intake (as a yes or no variable) nor amount of fluid
drunk before bedtime was associated with nocturia. This
finding is consistent with accumulated anecdotal patient
reports. For most patients, fluid restriction frequently does
not work, except in cases in which patients clearly related
that they intentionally drank a large quantity of fluid late in
the evening before retiring (personal communication,
Jeffrey Weiss, July 14, 2004). When those patients ceased
drinking after supper, they tended to improve, if only a
little. Thus, reducing evening or bedtime fluid intake may
best be regarded as targeted advice for certain patients as
opposed to general advice for all. No studies could be iden-
tified linking nighttime fluid discontinuation to nocturia
reduction, although this recommendation appears in guide-
lines.1 Most patients with nocturia have reasoned that it is a
good idea to stop drinking before bedtime; so further in-
structions along these lines are frequently unhelpful. Be-
cause many patients may have fluid intake barely sufficient
to meet their physiologic needsFas well as related prob-
lems such as constipationFadvice to restrict fluids has po-
tential to cause more harm than benefit for some patients.
Data on 24-hour fluid intake showed no association be-
tween 24-hour intake and nocturia. With regard to coffee
use, coffee drinking over a 24-hour period reduced odds of
nocturia in bivariate analysis. These analyses would not
support restricting overall coffee usage to reduce nocturia.
Morning coffee use could act as a daytime diuretic and
therefore reduce nighttime voids.
Longitudinal analyses in this sample failed to demon-
strate any baseline risk factors that predicted future devel-
opment of nocturia. Further investigation into this puzzling
result showed that reporting nocturia was not stable over
time in this study. Between baseline and Year 2 follow-up,
more than 30% of the sample who initially reporting having
fewer than two episodes of nocturia 2 years later reported
having two or more episodes. In addition, 60% of those
with two or more episodes at baseline reported fewer than
two episodes by Year 2 follow-up.
These findings called into question the stability of the
answer to the nocturia question and how stable nocturia is
as a symptom. There are four lines of evidence suggesting
that the nocturia question used in this survey produced ac-
curate answers. First, the question used here has reasonable
face validity and matches well with the International Con-
tinence Society definition.1 Second, age- and sex-specific
prevalence data on nocturia derived here match prevalence
estimates from a recently published study derived from a
population-based sample of 92,491 respondents.28 Third,
baseline cross-sectional analyses give similar results to the
Year 6 follow-up cross-sectional analyses. Fourth, when
considering only those with nocturia reports at the extremes
(those with no nocturia and those with 3 episodes), there
was greater stability of these data.
Although many individuals gave markedly different
answers to the nocturia question over time, the mean re-
sponse of the group changed little. Considering baseline and
Year 2 follow-up samples to be two sets of cross-sectional
data, for example, the data appear much more stable; the
prevalence of nocturia of two or more episodes for those
aged 60 and older (baseline) is 32.3%, and the prevalence
for those aged 62 and older (Year 2 follow-up) is 34.3%.
Considered this way, the 2-year incidence appears to be 2%.
There are additional limitations to these analyses. The
lack of specificity of certain questions limits interpretation.
Participants answered questions about coffee intake but did
not specify whether the coffee was decaffeinated or whether
they drank it in the morning or afternoon. Additionally,
other sources of caffeine in the diet or in over-the-counter
medications could not be assessed. Participants spoke about
fluids before bedtime but gave no information about the
length of the interval between intake and bedtime. As for
diuretic use, these data are not specific as to the medical
indication for diuretic use. Use may have been for hyper-
tension management, edema states, or congestive heart
failure; for any individual, the indication for a diuretic may
have been different in 1984 as opposed to 2005. As for the
diagnoses of hypertension and diabetes mellitus, there were
likely some misclassifications. Participants may have be-
lieved they had hypertension or diabetes mellitus but did
not, or may have had it but were not yet aware. Several
aspects of hypertension and diabetes mellitus management
have changed significantly over the past 20 years. The di-
agnostic criteria now used for diabetes mellitus or hyper-
tension result in more individuals being diagnosed with
these conditions today than in the 1980s.29,30 For diabetes
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mellitus and hypertension, new pharmaceuticals have been
developed over the past 20 years (e.g., for hypertension,
calcium-channel blockers and angiotensin-converting en-
zyme inhibitors; for diabetes mellitus, biguanides and glita-
zones). The effect of these diagnostic and therapeutic
changes in relation to findings presented here is unclear.
Despite these limitations, these findings add to the lit-
erature on nocturia. These data are consistent with previous
reports demonstrating an association between hypertension
and nocturia. For the clinician, the lack of association be-
tween nocturia and nighttime fluid intake or total coffee
intake is noteworthy. This suggests that providers who
routinely advocate fluid management interventions for noc-
turia should reassess whether this strategy benefits their
patients.
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